Qube Research & Technologies Ltd - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 93 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2024. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q1 2024$9,780,709
+9362.4%
231,004
+9237.3%
0.02%
Q4 2023$103,364
-69.0%
2,474
-81.9%
0.00%
-100.0%
Q1 2023$333,03813,6940.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2024
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 650,089$27,95412.84%
Analyst IMS Investment Management Services Ltd. 13,557$5830.02%
LRI Investments, LLC 2,000$85,7780.01%
Gladius Capital Management LP 761$32,7010.00%
RHUMBLINE ADVISERS 12,625$542,4900.00%
Lindbrook Capital, LLC 142$6,1020.00%
Covestor Ltd 26$10.00%
Red Tortoise LLC 40$1,7190.00%
OSAIC HOLDINGS, INC. 199$8,5510.00%
Parallel Advisors, LLC 19$8160.00%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders